MX1 - December 2024 Half Year Results Presentation
| Stock | Micro-X Ltd (MX1.ASX) |
|---|---|
| Release Time | 28 Feb 2025, 2:32 p.m. |
| Price Sensitive | Yes |
Micro-X Delivers Strong H1 2025 Results
- Focused on Medical Imaging, discontinuing Argus operations
- Secured $5.6M Billion Prima partnership and $6M capital raise
- Awarded $25M ARPA-H contract for portable Full Body CT scanner
Micro-X Ltd has reported its H1 2025 results, resetting its strategy to focus on Medical Imaging and discontinuing its Argus operations. The company has secured a $5.6M partnership with Billion Prima to commercialize its NEX technology baggage scanner in Southeast Asia, as well as a $6M capital raise. Micro-X also won a $25M contract from ARPA-H to develop a portable Full Body CT scanner, building on its Head CT technology. The company is targeting larger opportunities with its Rover Plus mobile X-Ray system and establishing sales channels for its Medical CT solutions. In the Security division, Micro-X is monetizing its Checkpoint and Baggage Scanner developments with the US Department of Homeland Security, while negotiating further partnerships to take the technology to market. The company has narrowed its funding gap, with $0.7M operating cash outflow in H1 2025 and significant new contracts secured, including a $12.5M ARPA-H deal and $6.1M DHS extension.
Micro-X expects to receive up to $25M in funding from ARPA-H over 5 years for the development of its portable Full Body CT scanner, with the initial $12.5M contract covering the first 2 years.
Micro-X is focused on executing its Medical Imaging strategy, with plans to commence Head CT imaging trials in Australian hospitals in 2025 and evaluate opportunities for its Rover Plus mobile X-Ray system. The company is also working to commercialize its Security technology through partnerships, while its core focus remains on the development and commercialization of its Medical CT solutions.